SensorionSTU:RFM -0.64%29 EBITDA Margin % is 3,297.00% as of Dec. 2025. GuruFocus rates STU:RFM with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, Sensorion ranks worse than 105932.1% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sensorion's EBITDA for the
six
months ended in Dec. 2025 was €-13.19 Mil. Sensorion's Revenue for the
six
months ended in Dec. 2025 was €-0.40 Mil. Therefore, Sensorion's EBITDA margin for the quarter that ended in Dec. 2025 was 3,297.00%.
Sensorion (STU:RFM) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sensorion EBITDA Margin % Related Terms
Sensorion EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sensorion's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:RFM vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Sensorion's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sensorion EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sensorion's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sensorion's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sensorion (STU:RFM) has a EBITDA Margin % of 3,297.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sensorion and its competitors. According to the industry distribution chart, Sensorion ranks #999999 out of 944 companies in the Biotechnology industry.
Is Sensorion's EBITDA Margin % too high?
Sensorion's current EBITDA Margin % is 3,297.00%. Based on the distribution chart, Sensorion ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sensorion has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sensorion's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sensorion ranks #999999 out of 944 companies for EBITDA Margin %. This places Sensorion in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sensorion and its competitors. Sensorion's current EBITDA Margin % is 3,297.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensorion stock overvalued right now?
Sensorion (STU:RFM) has a current EBITDA Margin % of 3,297.00%. The current EBITDA Margin % is 3,297.00%. Sensorion's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sensorion (STU:RFM), the current EBITDA Margin % is 3,297.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
29GF Score
Get the complete analysis for STU:RFM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:RFM has been successfully added to your 
